4.8 Article

Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages

Marah C. Runtsch et al.

Summary: Itaconate and 4-octyl itaconate inhibit M2 macrophage polarization and metabolic remodeling by suppressing JAK1 phosphorylation and kinase activity. This discovery provides a new strategy to inhibit JAK1 in M2 macrophage-driven diseases.

CELL METABOLISM (2022)

Article Oncology

Immunometabolic Interplay in the Tumor Microenvironment

Irem Kaymak et al.

Summary: The study discusses the metabolic characteristics of immune cells in the tumor microenvironment and proposes future research directions.

CANCER CELL (2021)

Article Cell Biology

Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses

Jennifer A. Lo et al.

Summary: Studies suggest that patients responding to immune checkpoint inhibitors typically have higher levels of tumor-specific neoantigens and higher expression of pigmentation-related genes in tumors. Expansion of CD8(+) T cells specific for melanocyte antigens was observed only in patients responding to anti-PD-1 therapy, indicating potential breakdown of tolerance toward tumor-lineage self-antigens. Epitope spreading toward wild-type tumor-lineage self-antigens represents a common pathway for successful response to ICI.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Itaconate confers tolerance to late NLRP3 inflammasome activation

Monika Bambouskova et al.

Summary: Itaconate, induced upon TLR stimulation, regulates NLRP3 inflammasome activation and synergizes with iNOS, establishing tolerance to NLRP3 inflammasome in inflammatory macrophages. Mechanistically, itaconate prevents full caspase-1 activation and gasdermin D processing, potentially leading to pyroptotic cell death and tissue damage if not controlled.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy

Mahmoud S. Alghamri et al.

Summary: The efficacy of immune-stimulatory gene therapy is enhanced in mIDH1 gliomas due to the reprogramming of infiltrating myeloid cells, mainly non-suppressive neutrophils and pre-neutrophils, in the tumor microenvironment. This reprogramming is triggered by granulocyte colony-stimulating factor (G-CSF) secreted by mIDH1 glioma stem/progenitor-like cells, leading to non-inhibitory myeloid cells within the tumor microenvironment and enhancing the therapy's effectiveness.

SCIENCE ADVANCES (2021)

Article Multidisciplinary Sciences

A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages

Thomas B. Huffaker et al.

Summary: This study highlights the role of IFN gamma and STAT1-inducible Nampt in shaping the metabolic program and function of tumor-associated macrophages. IFNy can polarize macrophages in the tumour microenvironment to an inflammatory state, impacting their anti-tumour function. The activation of NRE1, a regulatory region within the NAMPT gene, by IFNy-driven STAT1 plays a key role in regulating TAM functions.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

ASCL1 represses a SOX9+ neural crest stem-like state in small cell lung cancer

Rachelle R. Olsen et al.

Summary: ASCL1 is a critical oncogenic driver in SCLC, promoting neuroendocrine fate while repressing a SOX9+ state. Its loss leads to the emergence of nonendodermal stem-like fate and impacts tumor progression.

GENES & DEVELOPMENT (2021)

Review Immunology

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Filippo Veglia et al.

Summary: MDSCs are pathologically activated cells with potent immunosuppressive activity, closely associated with poor clinical outcomes in diseases like cancer. Recent studies have identified key distinctions between MDSCs and classical neutrophils and monocytes, providing new insights into therapeutic targeting for cancer and autoimmune diseases through understanding their genomic and metabolic characteristics. Emerging data also suggest potential involvement of MDSCs in pregnancy, neonatal biology, and COVID-19.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Cytokine-like Roles for Metabolites in Immunity

Zbigniew Zaslona et al.

MOLECULAR CELL (2020)

Review Cell Biology

Amino Assests: How Amino Acids Support Immunity

Beth Kelly et al.

CELL METABOLISM (2020)

Review Oncology

Metabolism of immune cells in cancer

Robert D. Leone et al.

NATURE REVIEWS CANCER (2020)

Review Immunology

Metabolic coordination of T cell quiescence and activation

Nicole M. Chapman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Immunology

The Immunomodulatory Potential of the Metabolite Itaconate

Alexander Hooftman et al.

TRENDS IN IMMUNOLOGY (2019)

Review Immunology

Itaconate: the poster child of metabolic reprogramming in macrophage function

Luke A. J. O'Neill et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

Lukas Bunse et al.

NATURE MEDICINE (2018)

Article Medicine, Research & Experimental

Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors

Jonathan M. Weiss et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Multidisciplinary Sciences

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1

Evanna L. Mills et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

The Human Knockout Gene CLYBL Connects Itaconate to Vitamin B12

Hongying Shen et al.

Article Cell Biology

Serine Is an Essential Metabolite for Effector T Cell Expansion

Eric H. Ma et al.

CELL METABOLISM (2017)

Review Cell Biology

Food Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense

Harding H. Luan et al.

CELL METABOLISM (2016)

Article Biochemistry & Molecular Biology

Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels

Thekla Cordes et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Multidisciplinary Sciences

S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate

Petros A. Tyrakis et al.

NATURE (2016)

Article Genetics & Heredity

NRF2 regulates serine biosynthesis in non-small cell lung cancer

Gina M. DeNicola et al.

NATURE GENETICS (2015)

Article Oncology

Multiple murine BRaf V600E melanoma cell lines with sensitivity to PLX4032

Molly H. Jenkins et al.

PIGMENT CELL & MELANOMA RESEARCH (2014)

Article Multidisciplinary Sciences

Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma

Ping Yuan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production

Alessandro Michelucci et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development

Courtney Smith et al.

CANCER DISCOVERY (2012)

Article Chemistry, Multidisciplinary

Itaconic Acid Is a Mammalian Metabolite Induced during Macrophage Activation

Cheryl L. Strelko et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)